Application of C1-Esterase Inhibitor During Reperfusion of Ischemic Myocardium
- 17 December 2001
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 104 (25), 3125-3131
- https://doi.org/10.1161/hc5001.100835
Abstract
Background— Complement activation during reperfusion of ischemic myocardium augments myocardial injury, and complement inhibition with C1-esterase inhibitor (C1-INH) at the time of reperfusion exer...Keywords
This publication has 28 references indexed in Scilit:
- Cytokines and the Microcirculation in Ischemia and ReperfusionJournal of Molecular and Cellular Cardiology, 1998
- Factor XIIa activation of plasminogen is enhanced by contact activating surfaces and Zn2+Blood Coagulation & Fibrinolysis, 1997
- Myocardial oedema: a preventable cause of reperfusion injury?Cardiovascular Research, 1993
- Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.Journal of Clinical Investigation, 1991
- Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarctionCardiovascular Research, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Inactivation of kallikrein in human plasma.Journal of Clinical Investigation, 1983
- Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in PlasmaJournal of Clinical Investigation, 1982
- The “No-Reflow” Phenomenon after Temporary Coronary Occlusion in the DogJournal of Clinical Investigation, 1974
- Activation of plasminogen by human plasma kallikreinBiochemical and Biophysical Research Communications, 1969